IL11 and hepatocellular carcinoma: YTHDF2 silencing provoked tumor-promoting inflammation, vascular reconstruction, and energy metabolism reprogramming in hepatocellular carcinoma by inhibiting the degradation of m6A-modified IL11 (interleukin 11) and SERPINE2 (serpin family E member 2) transcripts (14).